Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by schocoron Jan 27, 2021 10:42am
96 Views
Post# 32398452

RE:RE:RE:With a minimum Rate of Return or Growth of 7% =

RE:RE:RE:With a minimum Rate of Return or Growth of 7% =
Benedict16th wrote: No, you are absolutely wrong or trying to be. The original motto narrative was " GUD will grow faster than Paladin given the cash and GUD will have more drugs than Pfizer in Canada” only after sequential misses and debacles with Meir, the narrative changed to Grandkids, but they did not specify how old investors Grand Kids would have to be to get a return. Nearly One billion dollar at hand assets is now worth 600 million. Would anyone invest if they expected nearly 50% capital Losses. Let’s get real it is not defendable on any financial investment metrics or analysis no matter how it is turned or shacked. So if you have been since inception and you are happy with GUD results do not tell so to your spouse or friends they may question your sanity


I only too my first bite of GUD in Jan 2021 - note the term first bite. This means I can continue to deploy capital if I feel it is a good investment in the future. I do think this stock is good value now.
<< Previous
Bullboard Posts
Next >>